99mTc-DPD scintigraphy as a novel imaging modality for identification of skeletal muscle amyloid deposition in light-chain amyloidosis
暂无分享,去创建一个
[1] J. Holton,et al. Transthyretin V122I amyloidosis with clinical and histological evidence of amyloid neuropathy and myopathy , 2015, Neuromuscular Disorders.
[2] P. Hawkins,et al. Utility and limitations of 3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in systemic amyloidosis. , 2014, European heart journal cardiovascular Imaging.
[3] M. Pepys,et al. Evaluation of systemic amyloidosis by scintigraphy with 123I-labeled serum amyloid P component. , 1990, The New England journal of medicine.
[4] R. Kyle,et al. Primary systemic amyloidosis: clinical and laboratory features in 474 cases. , 1995, Seminars in hematology.